NEAM
LLY icon

New England Asset Management’s Eli Lilly LLY Stock Holding History

New England Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,193
Closed -$2.44M – 104
2023
Q4 		$2.44M Sell
4,193
-517
-11% -$302K 0.39% 72
2023
Q3 		$2.53M Sell
4,710
-6,650
-59% -$3.43M 0.42% 67
2023
Q2 		$5.33M Hold
11,360
– – 0.77% 45
2023
Q1 		$3.9M Sell
11,360
-454
-4% -$153K 0.58% 55
2022
Q4 		$4.32M Sell
11,814
-9,100
-44% -$3.23M 0.08% 55
2022
Q3 		$6.76M Sell
20,914
-23,250
-53% -$7.37M 0.12% 34
2022
Q2 		$14.3M Buy
44,164
+750
+2% +$225K 0.24% 14
2022
Q1 		$12.4M Buy
43,414
+400
+0.9% +$103K 0.2% 15
2021
Q4 		$11.9M Buy
43,014
+3,650
+9% +$925K 0.18% 17
2021
Q3 		$9.1M Buy
39,364
+3,605
+10% +$890K 0.16% 18
2021
Q2 		$8.21M Buy
35,759
+1,050
+3% +$211K 0.15% 19
2021
Q1 		$6.48M Sell
34,709
-4,050
-10% -$792K 0.13% 26
2020
Q4 		$6.54M Buy
38,759
+900
+2% +$134K 0.13% 23
2020
Q3 		$5.6M Sell
37,859
-1,500
-4% -$232K 0.13% 27
2020
Q2 		$6.46M Sell
39,359
-3,470
-8% -$533K 0.16% 21
2020
Q1 		$5.94M Buy
42,829
+2,240
+6% +$308K 0.14% 23
2019
Q4 		$5.33M Sell
40,589
-600
-1% -$69.5K 0.09% 35
2019
Q3 		$4.61M Hold
41,189
– – 0.09% 38
2019
Q2 		$4.56M Sell
41,189
-364
-0.9% -$42.9K 0.09% 35
2019
Q1 		$5.39M Sell
41,553
-4,627
-10% -$563K 0.1% 32
2018
Q4 		$5.34M Buy
46,180
+1,600
+4% +$179K 0.11% 25
2018
Q3 		$4.78M Buy
44,580
+30
+0.1% +$3K 0.08% 32
2018
Q2 		$3.8M Buy
44,550
+4,750
+12% +$390K 0.07% 38
2018
Q1 		$3.08M Buy
39,800
+3,100
+8% +$250K 0.06% 45
2017
Q4 		$3.1M Buy
36,700
+200
+0.5% +$17K 0.06% 47
2017
Q3 		$3.12M Buy
36,500
+200
+0.6% +$16.4K 0.07% 45
2017
Q2 		$2.99M Sell
36,300
-800
-2% -$65.3K 0.1% 43
2017
Q1 		$3.12M Buy
37,100
+3,350
+10% +$268K 0.05% 48
2016
Q4 		$2.48M Buy
33,750
+4,750
+16% +$354K 0.07% 52
2016
Q3 		$2.33M Buy
29,000
+300
+1% +$24K 0.09% 55
2016
Q2 		$2.26M Buy
28,700
+200
+0.7% +$15.1K 0.08% 63
2016
Q1 		$2.05M Sell
28,500
-6,400
-18% -$484K 0.06% 63
2015
Q4 		$2.94M Sell
34,900
-900
-3% -$74.7K 0.07% 36
2015
Q3 		$3M Buy
35,800
+2,900
+9% +$245K 0.08% 55
2015
Q2 		$2.75M Buy
32,900
+800
+2% +$61K 0.07% 65
2015
Q1 		$2.33M Buy
32,100
+200
+0.6% +$14.2K 0.06% 71
2014
Q4 		$2.2M Hold
31,900
– – 0.05% 72
2014
Q3 		$2.07M Sell
31,900
-6,400
-17% -$405K 0.05% 84
2014
Q2 		$2.38M Buy
38,300
+300
+0.8% +$17.9K 0.06% 88
2014
Q1 		$2.24M Sell
38,000
-1,000
-3% -$55.8K 0.06% 84
2013
Q4 		$1.99M Buy
39,000
+1,300
+3% +$65.1K 0.05% 94
2013
Q3 		$1.9M Buy
37,700
+13,300
+55% +$696K 0.06% 92
2013
Q2 		$1.2M Buy
+24,400
New +$1.33M 0.04% 97

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

New England Asset Management's LLY Position: Q1 2024 in Review

New England Asset Management sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 4,193 shares — an estimated $2.44M sold.

New England Asset Management first reported a position in LLY in Q2 2013 and held it in 43 quarters. The position peaked at $14.3M in Q2 2022. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • New England Asset Management reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
  • New England Asset Management sold 4,193 Eli Lilly shares in Q1 2024, an estimated $2.44M.
  • New England Asset Management first reported a position in Eli Lilly in Q2 2013 and held it in 43 quarters.
  • New England Asset Management's Eli Lilly position peaked at $14.3M in Q2 2022.
  • 3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on New England Asset Management's 13F filing for Q1 2024, filed 15 May 2024.